The AHSN Network has supported many innovators to help advance our health and care system. Find out more about successful innovations supported by the NHS.
The Volunteer Platform (WAHT Edition) is a clinical trial management tool developed in partnership with Worcestershire Acute Hospitals NHS Trust (WAHT) and Being Guided. The Platform (to be renamed) aimed to provide an interface between patients and research staff, simplifying practices to improve the experience of patients and staff participating in research.
Refero connects clinical workforces to patients, other carers and citizens, quickly, simply and cost effectively. It has been proven to work across organisational boundaries and is now NHS approved and is designed to work with standard technology toolsets already used.
The Optilume Drug Coated Balloon (DCB) procedure is an innovative treatment for urethral stricture in adult males >18 years old. It is novel compared to existing endoscopic standard of care as it incorporates urethral dilation, to widen the strictured area, with an anti-proliferative drug (Paclitaxel) which is delivered circumferentially along the strictured inner urethral wall to prevent the fibrotic tissue response associated with stricture recurrence. The procedure itself follows established practices for urethral stricture with the ability to be performed via direct endoscopic visualization under local anaesthesia in an outpatient setting.
Aparito is a med-tech company specialising in capturing patient generated data and digital endpoints remotely, with a specific expertise in decentralised/ hybrid studies. As a leading provider of mHealth and remote patient monitoring technology with specialist regulatory and clinical expertise, with our technology it is possible to capture Real-World Patient Data through a variety of sources. These include eQuestionnaires, videos, voice, pictures and wearable device integration.
The ‘Whose Shoes?®’ approach, created by Gill Phillips, is an engaging approach to coproduction, used in over 80 NHS trusts, universities and more.
ADI are one of the UK’s leading digital health platform providers. They work with health and care organisations to ensure patients, and everyone involved in their care, have access to the right digital tools. They create and deploy digital applications designed to allow straightforward access to NHS Services.
Selfit is a digital robotic care startup based in Israel, with early operations in the UK. The company has developed a unique human-machine interaction for the ageing population focused on physical and congnitive health. Some of the applications are rehabilitation related (Neuro, Cardiac, Geriatrics) others are designed for prevention and wellness phases (elderly falls, cognitive impairments). The robot is currently installed in several facilities in Israel and UK.
The COVID-19 pandemic resulted in a critical Personal Protective Equipment (PPE) shortage across the West Midlands region and throughout the UK. Well known for its manufacturing capabilities, and world-class innovation infrastructure, the West Midlands was well placed to respond to the region’s life-threatening shortage of PPE within the community, care homes, and NHS.
Physiobuddie is an innovative therapy service that provides its users with step-by-step progressive rehabilitation via the following mediums: expert help, video tutorials and information sections. The support system is bespoke, pre-designed and progresses in line with the service users rehabilitation ability. The flexibility and functionality offered empowers the patient suffering from a wide range of needs and assists all abilities. Physiobuddie offers increased access to physiotherapy services without requiring physiotherapy staff (faceless or face-to-face) The service provides daily rehabilitation and advice to ensure optimal self-management by following the parameters of the program set. Communication can be provided by email and via app messages.
Oxford Heartbeat’s medical device software PreSize® Neurovascular helps clinicians make surgical decisions with greater accuracy and confidence. Use of PreSize® is aimed at significantly reducing risks associated with stenting procedures, as clinicians are able to virtually test and compare the behaviour of stents in a patient’s cerebral blood vessels before surgery, selecting the best one for each patient.
The Health Innovation Network (HIN) has been working in partnership with Coordinate My Care (CMC), to explore implementing CMC, an electronic urgent care planning service, in care homes.
Dignio offer a solution built to accommodate a seamless journey for individuals and care providers across increasingly complex care needs (self-management, domiciliary care, residential care, end of life care). The aim is to help keep people out of hospital, and in the safe hands of their care team in the comfort of their home. They provide a modern, easy to use remote care platform and connected devices to alert professionals if they need to act, and to engage people in their care. Health and social care teams across a region can use Dignio to monitor a single illness or a range of conditions. This has led to significantly reduced hospital admissions, and is saving healthcare millions of pounds.
